Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

ST1571 Anti-FCGR2A Mouse mAb (3E8)

Anti-FCGR2A, mouse monoclonal, clone 3E8, recognizes the FCGR2A protein in human. It is validated for use in ELISA and Western blotting.

Anti-FCGR2A Mouse mAb (3E8) MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Anti-Fc Fragment Low Affinity IIa Receptor, Anti-CD32

ST1571
  
Purchase on Sigma-Aldrich

Přehled

Replacement Information

Tabulka spec. kláve

Species ReactivityHostAntibody Type
HMMonoclonal Antibody
Description
OverviewRecognizes the FCGR2A protein.
Catalogue NumberST1571
Brand Family Calbiochem®
SynonymsAnti-Fc Fragment Low Affinity IIa Receptor, Anti-CD32
Application Data
Detection of human FCGR2A by immunoblotting. Sample: Partial, recombinant, human FCGR2A protein. Primary antibody: Anti-FCGR2A Mouse mAb (3E8) (Cat. No. ST1571) (1-5 µg/ml). Detection: chemiluminescence.
References
Product Information
FormLiquid
FormulationIn PBS, pH 7.2.
PreservativeNone
Quality LevelMQ100
Applications
Key Applications Enzyme-Linked Immunosorbent Assay
Immunoblotting (Western Blotting)
Application NotesELISA (see comments)
Immunoblotting (1-5 µg/ml)
Application CommentsFor ELISA, this antibody can be used as the capture antibody; recommended concentration is 10 ng/ml, 1 µg/well, 100 µl total volume. Variables associated with assay conditions will dictate the proper working dilution.
Biological Information
ImmunogenA recombinant polypeptide corresponding to amino acids 46-151 of human FCGR2A, expressed as a GST fusion protein
Clone3E8
HostMouse
IsotypeIgG2a
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Regulatory Review
Storage -20°C
Avoid freeze/thaw Avoid freeze/thaw
Do not freeze Ok to freeze
Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalogové číslo GTIN
ST1571 0

Documentation

Anti-FCGR2A Mouse mAb (3E8) MSDS

Title

Safety Data Sheet (SDS) 

Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision08-October-2010 RFH
SynonymsAnti-Fc Fragment Low Affinity IIa Receptor, Anti-CD32
ApplicationELISA (see comments)
Immunoblotting (1-5 µg/ml)
Application Data
Detection of human FCGR2A by immunoblotting. Sample: Partial, recombinant, human FCGR2A protein. Primary antibody: Anti-FCGR2A Mouse mAb (3E8) (Cat. No. ST1571) (1-5 µg/ml). Detection: chemiluminescence.
DescriptionPurified mouse monoclonal antibody. Recognizes the FCGR2A protein.
BackgroundThis protein is a member of a family of immunoglobulin Fc receptor genes found on the surface of many immune response cells. The protein encoded by this gene is a cell surface receptor found on phagocytic cells such as macrophages and neutrophils, and is involved in the process of phagocytosis and clearing of immune complexes.
HostMouse
ImmunogenA recombinant polypeptide corresponding to amino acids 46-151 of human FCGR2A, expressed as a GST fusion protein
Clone3E8
IsotypeIgG2a
Specieshuman
FormLiquid
FormulationIn PBS, pH 7.2.
PreservativeNone
CommentsFor ELISA, this antibody can be used as the capture antibody; recommended concentration is 10 ng/ml, 1 µg/well, 100 µl total volume. Variables associated with assay conditions will dictate the proper working dilution.
Storage Avoid freeze/thaw
-20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
Toxicity Regulatory Review